Trials / Sponsors / L & L Bio Co., Ltd., Ningbo, China
L & L Bio Co., Ltd., Ningbo, China
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cervical Cancer | Phase 2 / Phase 3 | 2025-10-01 |
| Recruiting | A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or Metastatic Solid Tumors Solid Tumor | Phase 1 / Phase 2 | 2024-06-19 |
| Terminated | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With A Solid Tumor | Phase 1 | 2022-11-30 |
| Recruiting | A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyp Solid Tumor, Lymphoma | Phase 1 | 2022-08-12 |